AVR
Anteris Technologies Global Corp.
Price Chart
Latest Quote
$9.60
+0.33 (+3.51%)
Current Price
| Previous Close | $9.27 |
| Open | $9.28 |
| Day High | $9.90 |
| Day Low | $9.28 |
| Volume | 490,913 |
Stock Information
| Shares Outstanding | 97.34M |
| Total Debt | $3.73M |
| Cash Equivalents | $282.70M |
| Revenue | $1.85M |
| Net Income | $-95.30M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $934.00M |
| EPS (TTM) | $-2.22 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $623.36M |
| Sales | $1.85M |
| Income | $-95.30M |
| Book/sh | $2.86 |
| Cash/sh | $2.90 |
| Employees | 174 |
Financial Ratios
| Quick Ratio | 20.66 |
| Current Ratio | 20.93 |
| Debt/Eq | 1.34 |
Returns & Margins
| ROA | -33.99% |
| ROE | -59.21% |
| Gross Margin | 74.28% |
| Operating Margin | -4859.72% |
Ownership
| Insider Ownership | 16.49% |
| Institutional Ownership | 66.09% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -9.79 |
| P/S | 504.59 |
| P/B | 3.35 |
Analyst Data
| Recommendation | none |
| Target Price | $15.33 |
Technical Indicators
| SMA20 | $9.21 |
| SMA50 | $7.42 |
| SMA200 | $5.68 |
| RSI | 62.04 |
| ATR | 0.5788 |
| Shares Float | 78.55M |
| Short Float | 7.95% |
| Short Ratio | 5.06 |
| Volatility | 0.73 |
| Rel Volume | 0.37 |
Performance History
| Week | +1.00% |
| Month | +26.75% |
| Quarter | +62.90% |
| 6 Months | +102.85% |
| YTD | +95.02% |
| Year | +139.28% |
| 10 Years | +71.34% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $9.60 | 490,913 |
| 2026-06-16 | $9.27 | 1,055,800 |
| 2026-06-15 | $9.42 | 855,500 |
| 2026-06-12 | $9.15 | 691,700 |
| 2026-06-11 | $9.31 | 978,000 |
| 2026-06-10 | $9.50 | 1,027,900 |
| 2026-06-09 | $9.47 | 1,696,500 |
| 2026-06-08 | $9.34 | 1,005,800 |
| 2026-06-05 | $9.64 | 1,332,000 |
| 2026-06-04 | $9.65 | 2,130,700 |
| 2026-06-03 | $8.95 | 1,061,400 |
| 2026-06-02 | $9.29 | 975,700 |
| 2026-06-01 | $9.10 | 2,097,700 |
| 2026-05-29 | $8.62 | 1,072,400 |
| 2026-05-28 | $8.77 | 867,200 |
| 2026-05-27 | $8.86 | 1,059,300 |
| 2026-05-26 | $9.08 | 1,613,800 |
| 2026-05-22 | $9.62 | 2,347,100 |
| 2026-05-21 | $9.00 | 2,204,900 |
| 2026-05-20 | $8.62 | 1,682,600 |
| 2026-05-19 | $7.70 | 1,648,200 |
| 2026-05-18 | $7.57 | 1,070,200 |
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
đ° Latest News
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial
Proactive âĸ 2026-06-08T23:22:00Z
Here's Why We're Not Too Worried About Anteris Technologies Global's (ASX:AVR) Cash Burn Situation
Simply Wall St. âĸ 2026-05-13T20:00:21Z
Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy
Proactive âĸ 2026-05-13T01:33:00Z
Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push
Proactive âĸ 2026-05-12T23:43:00Z
Anteris treats first US patients in DurAVR pivotal trial
Proactive âĸ 2026-05-07T01:45:00Z
Anteris secures US Medicare coverage for PARADIGM Trial as DurAVR study advances
Proactive âĸ 2026-05-07T01:45:00Z
Anteris Technologies enrolls First US patients in global PARADIGM trial for DurAVR heart valve
Proactive âĸ 2026-05-06T17:40:39Z
Small Cap Watch: Small Ordinaries edges higher as company news flow continues
Proactive âĸ 2026-05-06T00:11:00Z
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market
Proactive âĸ 2026-04-02T03:47:00Z
Anteris Technologies Global CEO Touts DurAVR Redesign, Durability Claims and TAVR Market Strategy
MarketBeat âĸ 2026-03-12T12:35:42Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | - | - | $1,015,229 | $2,354,604 |
| Cost Of Revenue | - | - | $1,858,021 | $2,902,328 |
| Total Revenue | - | - | $2,734,821 | $3,200,711 |
| Operating Revenue | - | - | $2,734,821 | $3,200,711 |
| Expenses | ||||
| Interest Expense | - | - | $67,089 | $648,709 |
| Total Expenses | - | - | $49,391,312 | $34,688,356 |
| Other Income Expense | - | - | $-467,876 | $1,362,172 |
| Other Non Operating Income Expenses | - | - | $790,025 | $2,055 |
| Net Non Operating Interest Income Expense | - | - | $360,970 | $-438,327 |
| Interest Expense Non Operating | - | - | $67,089 | $648,709 |
| Operating Expense | - | - | $47,533,291 | $31,786,028 |
| Other Operating Expenses | - | - | $-717,331 | $-1,243,839 |
| Selling And Marketing Expense | - | - | $1,086,200 | $806,278 |
| General And Administrative Expense | - | - | $15,959,498 | $14,407,146 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | - | - | $-46,021,841 | $-30,563,800 |
| Net Interest Income | - | - | $360,970 | $-438,327 |
| Interest Income | - | - | $428,059 | $210,382 |
| Normalized Income | - | - | $-44,763,940 | $-31,923,917 |
| Net Income From Continuing And Discontinued Operation | - | - | $-46,021,841 | $-30,563,800 |
| Total Operating Income As Reported | - | - | $-48,139,988 | $-31,114,275 |
| Net Income Common Stockholders | - | - | $-46,021,841 | $-30,563,800 |
| Net Income | - | - | $-46,021,841 | $-30,563,800 |
| Net Income Including Noncontrolling Interests | - | - | $-46,763,397 | $-30,563,800 |
| Net Income Continuous Operations | - | - | $-46,763,397 | $-30,563,800 |
| Pretax Income | - | - | $-46,763,397 | $-30,563,800 |
| Special Income Charges | - | - | $-632,864 | $0 |
| Interest Income Non Operating | - | - | $428,059 | $210,382 |
| Operating Income | - | - | $-46,656,491 | $-31,487,645 |
| Depreciation Amortization Depletion Income Statement | - | - | $314,931 | $226,353 |
| Depreciation And Amortization In Income Statement | - | - | $314,931 | $226,353 |
| Gross Profit | - | - | $876,800 | $298,383 |
| Per Share | ||||
| Diluted EPS | $-2.55 | $-3.77 | $-2.94 | $-2.26 |
| Basic EPS | $-2.55 | $-3.77 | $-2.94 | $-2.26 |
| Other | ||||
| Diluted Average Shares | $36,911,472 | $20,252,919 | $15,605,878 | $13,362,583 |
| Basic Average Shares | $36,911,472 | $20,252,919 | $15,605,878 | $13,362,583 |
| Tax Effect Of Unusual Items | - | - | $0 | $0 |
| Tax Rate For Calcs | - | - | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | - | - | $-44,280,684 | $-30,501,131 |
| Total Unusual Items | - | - | $-1,257,901 | $1,360,117 |
| Total Unusual Items Excluding Goodwill | - | - | $-1,257,901 | $1,360,117 |
| Reconciled Depreciation | - | - | $1,157,723 | $774,077 |
| EBITDA (Bullshit earnings) | - | - | $-45,538,585 | $-29,141,014 |
| EBIT | - | - | $-46,696,308 | $-29,915,091 |
| Diluted NI Availto Com Stockholders | - | - | $-46,021,841 | $-30,563,800 |
| Minority Interests | - | - | $741,556 | $0 |
| Tax Provision | - | - | $0 | $0 |
| Gain On Sale Of Ppe | - | - | $-501,247 | $0 |
| Other Special Charges | - | - | $131,617 | - |
| Gain On Sale Of Security | - | - | $-625,037 | $1,360,117 |
| Research And Development | - | - | $30,889,993 | $17,590,090 |
| Selling General And Administration | - | - | $17,045,698 | $15,213,424 |
| Other Gand A | - | - | $5,256,781 | $6,598,267 |
| Insurance And Claims | - | - | $840,747 | $643,877 |
| Salaries And Wages | - | - | $9,861,970 | $7,165,002 |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $18,890,762 | $8,425,868 | $9,761,292 |
| Total Assets | $30,527,440 | $15,985,506 | $21,433,693 |
| Total Non Current Assets | $6,305,706 | $3,745,831 | $2,684,554 |
| Non Current Accounts Receivable | $417,269 | - | - |
| Goodwill And Other Intangible Assets | $410,146 | $607,354 | $763,643 |
| Other Intangible Assets | $410,146 | $607,354 | $763,643 |
| Current Assets | $24,221,734 | $12,239,675 | $18,749,139 |
| Restricted Cash | $61,656 | $60,133 | - |
| Prepaid Assets | $845,129 | $1,016,295 | $892,073 |
| Inventory | $442,348 | $355,624 | $549,820 |
| Receivables | $1,845,382 | $1,514,566 | $1,852,064 |
| Other Receivables | $723,883 | $122,751 | $778,933 |
| Taxes Receivable | $713,943 | $950,889 | $868,143 |
| Accounts Receivable | $407,556 | $440,926 | $204,988 |
| Cash Cash Equivalents And Short Term Investments | $21,027,219 | $9,293,057 | $15,455,182 |
| Cash And Cash Equivalents | $21,027,219 | $9,293,057 | $15,455,182 |
| Cash Equivalents | $8,014,722 | $0 | $64,256 |
| Cash Financial | $13,012,497 | $9,293,057 | $15,390,926 |
| Debt | |||
| Total Debt | $1,689,538 | $952,787 | $4,136,174 |
| Long Term Debt And Capital Lease Obligation | $1,020,617 | $439,778 | $305,812 |
| Long Term Debt | $93,841 | - | - |
| Current Debt And Capital Lease Obligation | $668,921 | $513,009 | $3,830,362 |
| Current Debt | - | - | $3,376,688 |
| Other Current Borrowings | - | - | $3,376,688 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $11,629,367 | $6,952,284 | $10,908,758 |
| Total Non Current Liabilities Net Minority Interest | $2,173,083 | $907,038 | $712,355 |
| Other Non Current Liabilities | $93,841 | - | - |
| Current Liabilities | $9,456,284 | $6,045,246 | $10,196,403 |
| Other Current Liabilities | $922,683 | $936,516 | $1,299,937 |
| Payables And Accrued Expenses | $7,013,813 | $3,958,706 | $4,551,243 |
| Payables | $3,139,140 | $1,726,872 | $2,229,073 |
| Accounts Payable | $3,139,140 | $1,726,872 | $2,229,073 |
| Equity | |||
| Common Stock Equity | $19,300,908 | $9,033,222 | $10,524,935 |
| Total Equity Gross Minority Interest | $18,898,073 | $9,033,222 | $10,524,935 |
| Stockholders Equity | $19,300,908 | $9,033,222 | $10,524,935 |
| Gains Losses Not Affecting Retained Earnings | $-9,555,376 | $-9,937,305 | $-7,751,516 |
| Other Equity Adjustments | $-9,555,376 | $-9,937,305 | $-7,751,516 |
| Retained Earnings | $-200,096,813 | $-154,074,972 | $-123,511,172 |
| Other | |||
| Ordinary Shares Number | $35,939,816 | $35,939,816 | $35,939,816 |
| Share Issued | $35,939,816 | $35,939,816 | $35,939,816 |
| Tangible Book Value | $18,890,762 | $8,425,868 | $9,761,292 |
| Invested Capital | $19,394,749 | $9,033,222 | $13,901,623 |
| Working Capital | $14,765,450 | $6,194,429 | $8,552,736 |
| Capital Lease Obligations | $1,595,697 | $952,787 | $759,486 |
| Total Capitalization | $19,394,749 | $9,033,222 | $10,524,935 |
| Minority Interest | $-402,835 | $0 | - |
| Additional Paid In Capital | $11,625,608 | $3,256,299 | $319,282 |
| Capital Stock | $217,327,489 | $169,789,200 | $141,468,341 |
| Common Stock | $217,327,489 | $169,789,200 | $141,468,341 |
| Employee Benefits | $681,305 | $30,742 | $30,542 |
| Non Current Pension And Other Postretirement Benefit Plans | $48,157 | $30,742 | - |
| Long Term Capital Lease Obligation | $926,776 | $439,778 | $305,812 |
| Long Term Provisions | $471,161 | $436,518 | $376,001 |
| Current Capital Lease Obligation | $668,921 | $513,009 | $453,674 |
| Pensionand Other Post Retirement Benefit Plans Current | $850,867 | $637,015 | $514,861 |
| Current Accrued Expenses | $3,874,673 | $2,231,834 | $2,322,170 |
| Net PPE | $5,478,291 | $3,138,477 | $1,920,911 |
| Accumulated Depreciation | $-3,582,215 | $-2,695,083 | $-2,465,843 |
| Gross PPE | $9,060,506 | $5,833,560 | $4,386,754 |
| Construction In Progress | $492,273 | $0 | - |
| Other Properties | $1,486,510 | $943,263 | $723,624 |
| Machinery Furniture Equipment | $7,081,723 | $4,890,297 | $3,663,130 |
| Inventories Adjustments Allowances | $0 | $0 | $0 |
| Finished Goods | $126,687 | $5,286 | $107,091 |
| Work In Process | $53,531 | $82,229 | $194,372 |
| Raw Materials | $262,130 | $268,109 | $248,357 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-37,026,424 | $-31,082,691 | $-15,020,397 |
| Operating Activities | |||
| Operating Cash Flow | $-34,631,516 | $-29,416,702 | $-14,438,162 |
| Cash Flow From Continuing Operating Activities | $-34,631,516 | $-29,416,702 | $-14,438,162 |
| Operating Gains Losses | $1,126,284 | $-1,360,117 | $-78,604 |
| Investing Activities | |||
| Capital Expenditure | $-2,394,908 | $-1,665,989 | $-582,235 |
| Investing Cash Flow | $-2,581,673 | $-992,570 | $-886,068 |
| Cash Flow From Continuing Investing Activities | $-2,581,673 | $-992,570 | $-886,068 |
| Financing Activities | |||
| Issuance Of Capital Stock | $52,823,026 | $25,298,089 | $26,909,263 |
| Financing Cash Flow | $49,339,774 | $23,271,389 | $27,418,812 |
| Cash Flow From Continuing Financing Activities | $49,339,774 | $23,271,389 | $27,418,812 |
| Net Other Financing Charges | $-2,675,203 | $-1,051,246 | $-1,227,065 |
| Net Common Stock Issuance | $52,823,026 | $25,298,089 | $26,909,263 |
| Common Stock Issuance | $52,823,026 | $25,298,089 | $26,909,263 |
| Other | |||
| Repayment Of Debt | $-808,049 | $-975,454 | $-2,082,836 |
| Interest Paid Supplemental Data | $38,473 | $33,401 | $50,275 |
| End Cash Position | $21,088,875 | $9,353,190 | $15,455,182 |
| Beginning Cash Position | $9,353,190 | $15,455,182 | $3,353,725 |
| Effect Of Exchange Rate Changes | $-390,900 | $1,035,891 | $6,875 |
| Changes In Cash | $12,126,585 | $-7,137,883 | $12,094,582 |
| Net Issuance Payments Of Debt | $-808,049 | $-975,454 | $1,736,614 |
| Net Long Term Debt Issuance | $-808,049 | $-975,454 | $-47,154 |
| Long Term Debt Payments | $-808,049 | $-975,454 | $-47,154 |
| Net Business Purchase And Sale | $-213,000 | $0 | - |
| Purchase Of Business | $-213,000 | $0 | - |
| Net Intangibles Purchase And Sale | $-6,644 | $578,777 | $-9,367 |
| Sale Of Intangibles | $0 | $670,000 | $0 |
| Purchase Of Intangibles | $-6,644 | $-91,223 | $-9,367 |
| Net PPE Purchase And Sale | $-2,362,029 | $-1,571,347 | $-564,901 |
| Sale Of PPE | $26,235 | $3,419 | $7,967 |
| Purchase Of PPE | $-2,388,264 | $-1,574,766 | $-572,868 |
| Change In Working Capital | $3,986,243 | $-1,746,853 | $976,405 |
| Change In Payables And Accrued Expense | $4,417,979 | $-1,407,253 | $906,671 |
| Change In Inventory | $-86,725 | $194,196 | $-15,713 |
| Change In Receivables | $-345,011 | $-533,796 | $85,447 |
| Changes In Account Receivables | $-345,011 | $-533,796 | $85,447 |
| Other Non Cash Items | $101,856 | $542,974 | $940,157 |
| Stock Based Compensation | $5,759,775 | $2,937,017 | $254,850 |
| Depreciation Amortization Depletion | $1,157,723 | $774,077 | $640,087 |
| Depreciation And Amortization | $1,157,723 | $774,077 | $640,087 |
| Amortization Cash Flow | $204,019 | $200,153 | $201,882 |
| Amortization Of Intangibles | $204,019 | $200,153 | $201,882 |
| Depreciation | $953,704 | $573,924 | $438,205 |
| Gain Loss On Investment Securities | $-9,512 | $257,092 | $340,124 |
| Net Foreign Currency Exchange Gain Loss | $634,549 | $-1,617,209 | $-448,350 |
| Gain Loss On Sale Of PPE | $501,247 | $0 | $29,622 |
| Net Income From Continuing Operations | $-46,763,397 | $-30,563,800 | $-17,171,057 |
| Issuance Of Debt | - | $0 | $3,819,450 |
| Net Short Term Debt Issuance | - | $-936,090 | $1,783,768 |
| Short Term Debt Payments | - | $-936,090 | $-2,035,682 |
| Short Term Debt Issuance | - | $0 | $3,819,450 |
| Net Investment Purchase And Sale | - | $0 | $-311,800 |
| Purchase Of Investment | - | $0 | $-311,800 |
Fetched: 2026-06-17